JPS62114917A - Production of sterilized pills containing crude drugs as major active ingredients - Google Patents
Production of sterilized pills containing crude drugs as major active ingredientsInfo
- Publication number
- JPS62114917A JPS62114917A JP60256151A JP25615185A JPS62114917A JP S62114917 A JPS62114917 A JP S62114917A JP 60256151 A JP60256151 A JP 60256151A JP 25615185 A JP25615185 A JP 25615185A JP S62114917 A JPS62114917 A JP S62114917A
- Authority
- JP
- Japan
- Prior art keywords
- pills
- crude drugs
- drugs
- sterilized
- excipient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は、生薬類を主剤とする滅菌丸剤の製造法に関す
る。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing sterile pills containing crude drugs as the main ingredient.
丸剤は、古くから味やにおいが悪くて服用しにくい薬品
を投与したり、微量の生薬を長期にわたって服用するた
めの好適な剤型として重用されてきた。錠剤やカプセル
剤が普及した今日では、その存在価値がやや低下した感
があるが、薬品の吸収、作用が緩和であること、その剤
型に神秘性を感じることかできることなどの特徴を存す
る為、今日でしなおこの剤型が好んで使用される場合が
あり、生薬類を主剤とする医薬品にあっては特にこの傾
向が強い。Pills have long been used as a suitable dosage form for administering drugs that are difficult to take due to their unpleasant taste and odor, and for taking small amounts of herbal medicines over long periods of time. Nowadays, when tablets and capsules have become popular, it feels like their value has declined a little, but they still have characteristics such as ease of drug absorption and action, and a sense of mystery in their dosage form. Today, this dosage form is sometimes preferred, and this tendency is particularly strong for pharmaceuticals whose main ingredients are crude drugs.
しかしながら、生薬類を主剤とする丸剤の欠点の1つは
、生薬類に由来する種々の菌類を滅菌することが非常に
困難であるという点にある。通常の製丸操作によって製
造した生薬丸剤を、日周一般試験法37無菌試験法によ
り試験すると、1錠当たりの菌数カ月0万を超えること
ら希ではなく、この様な菌類を、例えば間欠滅菌法で撲
滅することはほとんど不可能である。勿論、加熱滅菌あ
るいは蒸気滅菌などは、生薬中の有効成分に変化を−き
たず恐れが強く、到底採用することができない。However, one of the drawbacks of pills based on herbal medicines is that it is very difficult to sterilize various fungi derived from herbal medicines. When crude drug pills manufactured by normal pill-making operations are tested using the daily cycle general test method 37 sterility test method, it is not uncommon to find more than 100,000 bacteria per tablet. It is almost impossible to eradicate with sterilization methods. Of course, heat sterilization, steam sterilization, etc. are highly likely to cause changes in the active ingredients in the herbal medicine, and cannot be used at all.
本発明者は、有効成分を劣化せしめることなく、生薬丸
剤を有効に滅菌する方法について鋭意研究を続けた結果
、(+)生薬を、その重量の2〜3倍の柊儂度約75〜
81(容量)%のエチルアルコールに約24〜48時間
浸漬して滅菌し、一方(2)澱粉、小麦粉、寒梅粉など
の賦形剤を約110〜115℃で約3時間加熱乾燥滅菌
し、(3)上記の方法で別々に滅菌した材料(浸漬混合
物と加熱乾燥した賦形剤)を混合し、日周製剤総則6
丸剤の製法に従って製剤化することにより、菌数が1万
以下の丸剤を製造することができることを見い出し、本
発明を完成した。As a result of intensive research into a method for effectively sterilizing crude drug pills without deteriorating the active ingredients, the present inventor has found that (+) crude drugs with a holly degree of approximately 75 to 3 times their weight
Sterilize by immersing in 81 (volume)% ethyl alcohol for about 24 to 48 hours, while (2) heating and drying sterilize excipients such as starch, wheat flour, and Kanbai powder at about 110 to 115 ° C. for about 3 hours, (3) Mix the materials (immersion mixture and heat-dried excipient) that have been sterilized separately using the above method, and
The present invention was completed based on the discovery that pills containing 10,000 or less bacteria can be produced by formulating pills according to the pill manufacturing method.
本発明方法は、アルコールによって実質的な変性をきた
す有効成分を含んでいない全ての生薬丸剤に適用するこ
とができるが、一般に賦形剤に対して生薬の含mが少な
い丸剤の製造に有利である。The method of the present invention can be applied to all crude drug pills that do not contain active ingredients that are substantially denatured by alcohol; It's advantageous.
以下に実施例を挙げて本発明を更に詳細に説明する。The present invention will be explained in more detail with reference to Examples below.
実講pロー 強心剤丸剤
8局センソ350gを滅菌温水700gに浸し、軟化せ
しめて篩過(Iメツシュ)し、これに日動ジャコウ10
0g、日周ゴオウ250g、日周熊胆120g1日局す
フラン末120g、日周人参末120g、日周サイカク
末120gを粉砕して細末となした乙のを混合し、この
混合物に局方エヂルアルコール2500m12を加えて
浸漬、湿潤せしめ48時間放置する。Practical lecture P 8 cardiotonic pills Soak 350 g of Senso in 700 g of sterile warm water, soften it, pass through a sieve (I mesh), and add Nichido Musk 10 to this.
0g, 250g of diurnal gourd, 120g of diurnal bear bile, 120g of sour fur powder, 120g of diurnal ginseng powder, and 120g of diurnal rhinoceros powder were crushed into a fine powder, and mixed with Otsu, which was made into a fine powder. Add 2,500ml of alcohol to soak, moisten and leave for 48 hours.
別に寒梅粉300g、)ウモ[1コシデンプン1900
g、1]局は草末適量(210g)を混合し、115℃
にて3時間熱風乾燥滅菌したしの、及びデヒドロ酢酸ナ
トリウム5g1および要ずれば沸騰滅菌した練合水を先
のアルコール浸漬混合物に合してよく混和し、日周製剤
総則6.丸剤の製法に■じて丸剤20万粒を製し、無菌
室にて常温あるいは温風乾燥する。Separately, 300g of Kanbai powder,) Umo [1 starch 1900g
g, 1] Mix appropriate amount of grass powder (210g) and heat at 115℃
sterilized by hot air drying for 3 hours, 5 g of sodium dehydroacetate, and if necessary kneading water sterilized by boiling were added to the above alcohol soaking mixture and mixed well, and the diurnal preparation general rules 6. 200,000 pills are made according to the pill manufacturing method and dried in a sterile room at room temperature or with warm air.
実施例2 緩下剤 日周ダイオウ末900g、日周センナ末750g。Example 2 Laxative 900g of diurnal rhubarb powder, 750g of diurnal senna powder.
自局アロエ末450g、ケンゴン末100g、日周セン
キュウ末750g、日周ケイヒ末250g、日間ンヨウ
キョウ末250g、の混合物に局方エヂルアルコール7
000〜7500m12を加えて浸漬、湿潤せしめ48
時間放置する。A mixture of 450 g of local aloe powder, 100 g of Kengon powder, 750 g of diurnal senkyu powder, 250 g of diurnal cinnamon powder, and 250 g of diurnal fenugreek powder, and 7 ml of pharmacopoeia edyl alcohol.
Add 000 to 7500 m12 and immerse and moisten 48
Leave it for a while.
別に寒梅粉660g、日周薬用炭2g、日局トウモロコ
ンデンプン適量(約450g)を混合し、115℃で3
時間熱風乾燥滅菌したもの、及びデヒドロ酢酸ナトリウ
ム4g1日局カルボキシメチルセルロースカルシウム3
0g1及び要すれば沸騰滅菌した練合水を先のアルコー
ル浸漬混合物に合してよく混和し、日周製剤総則6.丸
剤の製法に錦して丸剤8万粒を製し、無菌室にて常温あ
るいは温風乾燥する。Separately, mix 660 g of Kanbai powder, 2 g of diurnal medicinal charcoal, and an appropriate amount of JP corn starch (approx. 450 g), and heat at 115℃ for 30 minutes.
Sterilized by hot air drying for 1 hour, and sodium dehydroacetate 4g 1 day carboxymethyl cellulose calcium 3
0g1 and, if necessary, boiling sterilized kneading water, mix well with the alcohol soaking mixture, and follow the general rules for diurnal preparations 6. 80,000 pills are made using the same pill manufacturing method and dried in a sterile room at room temperature or with warm air.
」二足の実施例Iに従って製造した丸剤中に存在する菌
数を日周一般試験法37.無菌試験法により試験したと
ころ、以下の表1に示す結果を得た。The number of bacteria present in the pills prepared according to Example I was determined according to diurnal general test method 37. When tested using a sterility test method, the results shown in Table 1 below were obtained.
表!、生菌数測定試験結果(平板混釈法)上記の表から
明らかな様に、本発明方法により製造された丸剤に含ま
れている生菌数は、全ロットについて1万以下であるこ
とがわかる。table! As is clear from the above table, the number of viable bacteria contained in the pills manufactured by the method of the present invention is 10,000 or less for all lots. I understand.
Claims (1)
〜81(容量)%のエチルアルコールに約24〜48時
間浸漬し、一方(2)賦形剤を約110〜115℃で約
3時間加熱乾燥し、(1)で得た浸漬混合物に(2)で
得た乾燥賦形剤を混合した後、常法に従って丸剤を製造
することからなる生薬類を主剤とする滅菌丸剤の製造法
。1. (1) The crude drug at a final concentration of approximately 75 times its weight.
The immersion mixture obtained in (1) was soaked in ~81% (by volume) ethyl alcohol for about 24-48 hours, while (2) the excipient was heated and dried at about 110-115°C for about 3 hours, and the dipping mixture obtained in (1) was soaked in (2). ) A method for producing sterilized pills containing crude drugs as the main ingredient, which consists of mixing the dry excipients obtained in step 1 and then producing pills according to a conventional method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60256151A JPH0660106B2 (en) | 1985-11-14 | 1985-11-14 | Manufacturing method of sterile pills mainly composed of crude drugs |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60256151A JPH0660106B2 (en) | 1985-11-14 | 1985-11-14 | Manufacturing method of sterile pills mainly composed of crude drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62114917A true JPS62114917A (en) | 1987-05-26 |
JPH0660106B2 JPH0660106B2 (en) | 1994-08-10 |
Family
ID=17288614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60256151A Expired - Lifetime JPH0660106B2 (en) | 1985-11-14 | 1985-11-14 | Manufacturing method of sterile pills mainly composed of crude drugs |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0660106B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003070285A1 (en) * | 2002-02-19 | 2003-08-28 | Resolution Chemicals Limited | Solvent-based sterilisation of pharmaceuticals |
US7524834B2 (en) | 1997-11-14 | 2009-04-28 | Astrazeneca Ab | Sterile powders, formulations, and methods for producing the same |
-
1985
- 1985-11-14 JP JP60256151A patent/JPH0660106B2/en not_active Expired - Lifetime
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7524834B2 (en) | 1997-11-14 | 2009-04-28 | Astrazeneca Ab | Sterile powders, formulations, and methods for producing the same |
WO2003070285A1 (en) * | 2002-02-19 | 2003-08-28 | Resolution Chemicals Limited | Solvent-based sterilisation of pharmaceuticals |
US8541399B2 (en) | 2002-02-19 | 2013-09-24 | Resolution Chemicals Limited | Solvent-based sterilisation of pharmaceuticals |
Also Published As
Publication number | Publication date |
---|---|
JPH0660106B2 (en) | 1994-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sollmann | A manual of pharmacology and its applications to therapeutics and toxicology | |
JPH03167129A (en) | Method for processing allium plant | |
CN103432287A (en) | Tea seed foot bath powder and preparation method thereof | |
CN106138190A (en) | A kind of external-use gel preparation, preparation method and its usage | |
CN105920439A (en) | Effective part composition containing corn stigma extract and preparation method and application of effective part composition | |
Shingadiya et al. | Standard manufacturing procedure and quality parameters of Kanakbindvarishta | |
CN101194995B (en) | Proprietary Chinese medicine for treating animal virus, bacterium and mix infection | |
JPS62114917A (en) | Production of sterilized pills containing crude drugs as major active ingredients | |
CN101780172B (en) | Bacteriostatic washing liquor with high bacteriostatic action and method for preparing same | |
JP3839438B2 (en) | Atopic disease prevention / treatment agent | |
US5980903A (en) | Composition for the treatment of viral infections including HIV | |
JPS62253353A (en) | Medicinal herb-containing noodle | |
CN105595346B (en) | A kind of liquid preparation and preparation method thereof for replenishing the calcium | |
JP2019532039A (en) | Composition comprising pollen and / or pistil extract, method of preparation and related uses | |
CN103919962A (en) | Kidney-yang deficiency treatment traditional Chinese medicine composition and preparation method thereof | |
CN112807468A (en) | Nerve-soothing and sleep-aiding spice composition and preparation method and application thereof | |
JPH07330621A (en) | Silkworm extract and silkworm cream containing the same extract as active ingredient | |
CN105687225B (en) | A kind of pharmaceutical composition for treating irritable bowel syndrome and its preparation method and application | |
JP6708916B1 (en) | Zhuang family pharmaceutical composition for regulating replenishment and method for preparing the same | |
Barrett | Olive Leaf Extract: The Mediterranean Healing Herb | |
Liu et al. | Preparation and Quality Evaluation of Gan Mai Dazao Oral Liquid | |
RU2098108C1 (en) | Apitherapeutic agent | |
CN105770187A (en) | Health food capable of improving immunity and preparing method thereof | |
RU2216204C2 (en) | Method of preparing seeds for obtaining of food germs | |
EP1338303B1 (en) | Detoxifying phytotherapeutic composition from two plant extracts and process for preparing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |